Skip to main content
. 2022 Apr 21;10(4):e32557. doi: 10.2196/32557

Table 4.

DRsa and CRsb for overcoming the identified limitations or barriers in digital health technologies for osteoporosis.

Identified limitation or barrier and related aspect Recommendation
App designers and developers without supporting information from clinicians, resulting in a very technologically focused and problem-oriented approach in the design of mHealth apps

Design perspective
  • DR1: involve all the stakeholders in all the stages of user requirements, design, and development using a participatory design approach (cocreation)


Clinical perspective
  • CR1: active participation in the design, development, and testing stages

Clinicians’ reluctance in adopting mHealth c apps as they envisage that they will replace them

Clinical perspective
  • CR1: adopt mHealth technologies in daily practices and in clinical care (measurement, assessment, and recording data)

  • CR2: recommend trustworthy apps to their patients

  • CR3: use mHealth apps to effectively communicate with patients and other health care professionals through the integration of wearables and IoTd

Lack of trustworthy and available smart tools and strict regulations on mHealth tools

Design perspective
  • DR1: use adaptive learning algorithms (eg, AIe and machine or deep learning) in the app to make more personalized recommendations and treatments

  • DR2: incorporate clinically validated monitoring, measurement, and assessment tools in the designed app


Clinical perspective
  • CR1: evaluate mHealth measurement and assessment tools by concerned clinical experts before disseminating them to public

Underestimation of the security risk and the elevated cost of implementing strong data security and privacy rules

Design perspective
  • DR1: implement stringent security regulations (eg, GDPRf [79]) to protect users’ information from any data penetration (security and privacy by design)

Available data are provider oriented rather than patient accessible; limited existing guidelines on how to optimize user interfaces for patients, providers, or both

Design perspective
  • DR1: allow patients to access their data (GDPR enforcement in design)

  • DR2: generate feedback and plans (for diet and exercises) based on the gathered data to keep patients engaged and motivated

Inconsistent data collection standards, complexity of data, and lack of quality assurance processes (data cannot be verified)

Design perspective
  • DR1: use passive and active gathering of data (medication, symptoms, nutrition management, and physical exercising), in addition to the data gathered from any wearables or IoT sensors


Clinical perspective
  • CR1: combine conventional clinical assessment with the app assessment

Difficulties in acquiring, analyzing, and applying structured and unstructured data to treat or manage diseases

Design perspective
  • DR1: apply AI-based techniques that help with the prediction, diagnosis, and treatment or management of diseases

Low retention rates of participants

Design perspective
  • DR1: provide valuable feedback to the user

  • DR2: use simple and straightforward interfaces

  • DR3: continuously update users’ data

  • DR4: offer financial incentives for healthy habit changes

aDR: design-related recommendation.

bCR: clinical recommendation.

cmHealth: mobile health.

dIoT: Internet of Things.

eAI: artificial intelligence.

fGDPR: General Data Protection Regulation.